Abbvie Therapeutics India Private Limited, a active private limited company, was established on 04 July 1994 in Bangalore, Karnataka, India. Engaging in eye care & ophthalmology clinics within the trade sector, it holds CIN: U33201KA1994PTC023162. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.00 Cr.
Formerly known as Allergan India Limited. It upholds a compliant status. Employing 386 professional, Its leadership includes Ajay Gopikisan Piramal (Director), Suresh Pattathil (Managing Director), Swati Ajay Piramal (Director). Past directors included Ranganathan Sridhar, Ramanathan Sundaram, Rajesh Sharma. Its latest AGM occurred on 19 August 2025, with the balance sheet filed on 31 March 2025. It is based at Prestige Obelisk Level 6 And Level 7 Kasturba Road, Bangalore, Karnataka, 560001.
U33201KA1994PTC023162
023162
04 July 1994
₹10.00 Cr
₹8.00 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Abbvie Therapeutics India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Gopikisan Piramal | Director | 29 Sep 2015 | Current |
| Suresh Pattathil | Managing Director | 10 Jul 2020 | Current |
| Swati Ajay Piramal | Director | 26 Mar 2002 | Current |
| Hong Liu Shi | Director | 11 Jan 2024 | Current |
| Vidhan Kedia | Director | 24 Jan 2023 | Current |
| Vivek Valsaraj | Director | 22 Feb 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Sep 2017 | Past |
| Pramod Abcsdd | Director | 18 Mar 2019 | Past |
| Pramod Abcsdd | Director | 11 Jun 2019 | Past |
| Pramod Abcsdd | Company Secretary | 12 Apr 2013 | Past |
| Pramod Abcsdd | Director | 01 Dec 2008 | Past |
| Pramod Abcsdd | Additional Director | 25 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Abbvie Therapeutics India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.86% increase. The company also saw a slight improvement in profitability, with a 7.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 33.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Abbvie Therapeutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Abbvie Therapeutics India has a workforce of 386 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Abbvie Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbvie Therapeutics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Abbvie Therapeutics India Private Limited last Annual general meeting of members was held on 19 Aug 2025 as per latest MCA records. was recorded as a recent event.
Abbvie Therapeutics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
Hong Liu Shi was appointed as a Director was appointed as a Director on 11 Jan 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
Progress on Vidhan Kedia was appointed as a Director was appointed as a Director on 24 Jan 2023 & has been associated with this company since 2 years 10 months . was documented.
The activity Vivek Valsaraj was appointed as a Director was appointed as a Director on 22 Feb 2022 & has been associated with this company since 3 years 9 months . was completed.
Perumal Chinnaiah was appointed as a Company Secretary was appointed as a Company Secretary on 03 Nov 2021 & has been associated with this company since 4 years 26 days . was recorded as a recent event.
The CIN of Abbvie Therapeutics India Private Limited is U33201KA1994PTC023162.
Abbvie Therapeutics India Private Limited is headquartered at Prestige Obelisk Level 6 And Level 7 Kasturba Road, Bangalore, Karnataka, 560001.
Abbvie Therapeutics India Private Limited was incorporated on 04 July 1994.
The current directors of Abbvie Therapeutics India Private Limited are
The primary industry of Abbvie Therapeutics India Private Limited is Trade.
Abbvie Therapeutics India Private Limited is unlisted.
The authorized capital of Abbvie Therapeutics India Private Limited is ₹10.00 Cr, and the paid-up capital is ₹8.00 Cr.
The compliance status of Abbvie Therapeutics India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX